Ajooni Biotech Limited — Others, 26-06-2025: Disclosure under SEBI Takeover Regulations

Ajooni Biotech’s promoters and persons acting in concert have confirmed no encumbrance or pledge on their shares during the financial year. This indicates stable promoter holding without any lien or charge, reflecting confidence in the company’s equity structure and providing reassurance to shareholders about ownership security.